Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

http://www.wikidata.org/entity/Q36630868

about

Trash or Treasure: extracellular microRNAs and cell-to-cell communication New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Clinical significance of microRNAs in chronic and acute human leukemia Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation microRNA: Diagnostic Perspective The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway.No Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma.Identification of microRNAs as potential biomarker for gastric cancer by system biological analysis.Integration analysis of microRNA and mRNA expression profiles in human peripheral blood lymphocytes cultured in modeled microgravity.Computational prediction of disease microRNAs in domestic animals Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.Proteogenomics of selective susceptibility to endotoxin using circulating acute phase biomarkers and bioassay development in sheep: a review.Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.Assay reproducibility in clinical studies of plasma miRNA Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression Role of microRNA-150 in solid tumors.Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML.Circulating microRNA signature of genotype-by-age interactions in the long-lived Ames dwarf mouse Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.Extracellular circulating viral microRNAs: current knowledge and perspectives Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).MicroRNAs as biomarkers in leukemia.miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.miRNAs in acute myeloid leukemia.The role of miR-150 in normal and malignant hematopoiesis.MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.MiR-150 Regulates Poststroke Cerebral Angiogenesis via Vascular Endothelial Growth Factor in Rats.MicroRNA in intervertebral disc degeneration.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.Translating microRNAs into biomarkers: What is new for pediatric cancer?Noncoding RNAs in Cancer Diagnosis.miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

P2860

Q21131238-9A3D936B-88D0-4B72-9EC1-B2179786C07E Q26748881-7DB84BF8-6D1F-493F-9B39-C56B9E7CFF2A Q26749533-8CA7EDE5-D9CD-43F0-93EB-0ECC799AE2D0 Q26770754-BA38DDCE-0CA4-468B-9C18-BE006DF83345 Q26797259-53287C06-76FC-4D68-A449-36A9387EA261 Q26825022-10ED454E-C260-40EA-95CA-2A29EA9B33CC Q28538780-5719B81A-7CA7-4069-AEA9-25EF88A17087 Q30353387-3A11A352-5B9B-42EF-A9AA-8906A830CADC Q33700748-DB2F3C7A-BDD2-47F1-BE6A-32201A6BE8DD Q33758852-DE16098A-889B-4BAE-9B31-D1C7982A62E0 Q33876262-9ED1A418-5FF5-4355-9472-9482A5A3869E Q33881021-7904F017-CDE8-4708-97F0-6ED6095C65CB Q34632505-1FEC000B-5E87-455A-8FB9-757E571DB0FD Q34982847-F6B138E5-2D44-4865-9486-8418CEE07D4C Q35035110-BB76954A-FD7B-4DBB-947F-C4B81CFE5162 Q35104729-631B5210-0470-463F-93CC-1671B812DD07 Q35211371-B523EEE9-FA54-433A-9079-B67C413FBEE1 Q35325816-06533B6B-646C-4DA8-A618-94BD95AB40F4 Q35543478-12E32AE2-127A-420E-A166-A515D6981ABE Q35562364-E7710B64-8E30-42DF-AF5D-388CF1BBC0F6 Q35803040-6BA3CAD0-99B6-4820-A425-F68DA8536782 Q35857675-5F85C40E-F486-4BCD-82F9-50F78482F2E1 Q36294264-A0886C3B-41D9-405E-9465-4A940428EF8C Q36410036-B35ACE63-DA8A-4C62-A128-D2BC2A637528 Q36913739-631A8879-5EFE-4D99-85C3-2FBC9163E0CF Q36948792-033C8B8A-1652-4E97-8B28-B0FEAA1EB994 Q36992190-EF636608-9BE8-457D-8B16-9DC86AFE11FA Q37043773-8E3B58A6-F62A-48B2-BEE3-4A95B82724F3 Q37421084-27A28D43-32BE-471A-A018-F3B6A3DF0E3A Q37619830-03F60D17-048E-48C2-808E-CF25DB304A5B Q37709531-0AF800B3-503F-4350-AFBE-0D23016A49FF Q38129726-056D5CBF-D0C0-4B8B-A62E-BD0649D43A46 Q38219675-A5CAA1EA-D29E-47AD-B0C3-2A4790D69B61 Q38293551-7959D5AB-D929-431F-91EB-4783489D0EFE Q38367405-8627D8EA-07BD-4F0D-BA79-E6E6C713B228 Q38637596-2D25109F-DB25-48FA-90D9-58F09C8AA520 Q38686015-0514B3CB-7FB8-47BF-BD53-88A5C4CB5D3C Q38810073-C66F00A6-D141-48B3-806D-AB6F621B5859 Q38885507-6B63F197-1661-4BE4-AD18-24BAE46F0879 Q38911621-8FDA4006-B658-450B-89B5-411615DC030B

P2860

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.

http://www.wikidata.org/entity/Q36630868

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@ast

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@en

type

label

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@ast

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@en

prefLabel

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@ast

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@en

P1433

Q36630868-9BA10A57-4BFA-474C-9DF3-79A08DA571F6

P1476

Q36630868-4331695F-4D04-469A-B337-7EFD913F75C4

P2093

Q36630868-0CDC3DDC-CAF6-4947-87EC-3765099BAD87

Q36630868-10BAEF24-0B74-4671-9B5B-B24CE09B867A

Q36630868-12C5C18D-A953-420B-AF83-FFDA01000992

Q36630868-3F118E0A-3EE5-4DC7-AB8E-BFF8BA2DC053

Q36630868-4036D970-9D55-4E77-8303-079EA35A3B35

Q36630868-424A23C8-62F7-4E67-A6ED-29F8C90BCE1D

Q36630868-51D7FED9-A61E-40FC-8172-155827C7B553

Q36630868-55E203ED-51C9-49D7-9A88-1C39CE8FAAC3

Q36630868-7258F564-DE1C-4C8C-BC4F-47114BC1F8A2

Q36630868-774962B8-86F6-46BF-959A-6A5EEAAB7A74

P2860

Q36630868-00634AA3-E0EA-4407-8A9E-4CD0C132A7A9

Q36630868-0D04A3D9-F510-4451-A310-B3BE0D7E9C00

Q36630868-15FA1DC6-77E3-4BF5-8778-849BE94986BB

Q36630868-167AF234-8611-42D3-AB20-327D9CF7AE11

Q36630868-17C387D6-39D4-4C16-9DB7-1F9E4E4BF2D6

Q36630868-1BA2C5E8-E7BC-4251-8FD7-32265EBE8570

Q36630868-20368E9A-86C9-4F03-9447-551C11524EA9

Q36630868-20E119A7-48B2-48B4-B18B-D49147C6E091

Q36630868-22D938D3-E6EC-4AFF-9FCD-A9492B51FC93

Q36630868-28466F87-20CF-4F23-B6CE-9103D33A5E34

P2888

Q36630868-133E0672-3BBC-43C9-AEBC-7326F436D6B3

P304

Q36630868-542C34AE-6A55-4E64-9923-E6651D85A243

P31

Q36630868-4FA9B2BE-BD4B-4F5B-9129-E920125F068F

P356

Q36630868-FBE09154-64E4-4111-94DF-74E81B290723

P478

Q36630868-15EE58C5-03E9-4B51-81A4-EB80714E560C

P50

Q36630868-5C066596-040E-438B-A268-BBF5AF6F8773

Q36630868-606370FA-8DD3-485D-877F-A27CEA5ECCB2

Q36630868-DC16AE16-8231-488D-9425-8AD74BE584E6

Q36630868-EA0E9FC9-DB15-4EE9-80DC-3D7D8372FC61

P577

Q36630868-17A25F76-1895-49FC-81A7-E3FFF912BB8D

P5875

Q36630868-7CEA3F6C-5D99-4CF7-AD13-5C89E5AE5773

P6179

Q36630868-55A5EEBD-00DF-4CB6-BBA2-98A8499D62D0

P698

Q36630868-2A3E2AFC-CCF3-4B7F-86B1-599AB26508C2

P921

Q36630868-3CF3F9CC-5D59-4339-9E72-001D100CA40E

Q36630868-E3823DD0-0DE5-41BE-9F76-78B1CCD4D2F4

P932

Q36630868-E630F14B-19C9-43AD-859E-4FE5211B64E7

P356

1479-5876-11-31

P1433

Journal of Translational Medicine

P1476

Circulating miR-150 and miR-34 ...... rs for acute myeloid leukemia.

@en

P2093

Ahmad Daher

http://www.w3.org/2001/XMLSchema#string

Bassam Badran

http://www.w3.org/2001/XMLSchema#string

Eva Hamade

http://www.w3.org/2001/XMLSchema#string

Fadwa Berri

http://www.w3.org/2001/XMLSchema#string

Hussein Fayyad-Kazan

http://www.w3.org/2001/XMLSchema#string

Mehdi Najar

http://www.w3.org/2001/XMLSchema#string

Mohammad Fayyad-Kazan

http://www.w3.org/2001/XMLSchema#string

Nader Hussein

http://www.w3.org/2001/XMLSchema#string

Nizar Bitar

http://www.w3.org/2001/XMLSchema#string

Philippe Lewalle

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients

Serum microRNAs are promising novel biomarkers

Intestinal epithelial cells secrete exosome-like vesicles

Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

Circulating microRNAs as stable blood-based markers for cancer detection.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

B lymphocytes secrete antigen-presenting vesicles

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Circulating miRNAs: promising biomarkers of human cancer

P2888

1479-5876-11-31

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-11-31

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Hussein Fayyad-Kazan

Mohammad Fayyad-Kazan

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235421375

http://www.w3.org/2001/XMLSchema#string

P6179

1045819942

http://www.w3.org/2001/XMLSchema#string

P698

23391324

http://www.w3.org/2001/XMLSchema#string

P921

P932

3579719

http://www.w3.org/2001/XMLSchema#string